Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
14.13 USD | +10.91% | +15.29% | -5.56% |
07:21pm | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
03:18pm | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.56% | 1.37B | |
+73.21% | 12.37B | |
-18.26% | 7.96B | |
+16.25% | 7.09B | |
+3.39% | 5.83B | |
+11.77% | 5.35B | |
+29.65% | 4.63B | |
-17.74% | 4B | |
-35.26% | 2.41B | |
+2.10% | 2B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Piper Sandler Adjusts NovoCure's Price Target to $90 From $100, Reiterates Overweight Rating